Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study

Takayuki Iwamoto, Yukari Uemura, Takashi Ishikawa, Azusa Jo, Hirohito Seki, Masahiro Kitada, Tsuyoshi Saito, Kimito Yamada, Shintaro Takao, Daisuke Takabatake, Toru Yokota, Yasuo Hozumi, Yuichiro Kikawa, Akimitsu Yamada, Uhi Toh, Hideki Nishimura, Hiroshi Kaise, Kazuhiko Yamagami, Reiki Nishimura, Kazutaka Narui, Hirofumi Mukai, Naruto Taira

Open source

DOI: 10.1007/s12282-026-01936-2
Published: 2026-11-06
Container: Breast Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12282-026-01936-2,
  title = {Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study},
  author = {Takayuki Iwamoto and Yukari Uemura and Takashi Ishikawa and Azusa Jo and Hirohito Seki and Masahiro Kitada and Tsuyoshi Saito and Kimito Yamada and Shintaro Takao and Daisuke Takabatake and Toru Yokota and Yasuo Hozumi and Yuichiro Kikawa and Akimitsu Yamada and Uhi Toh and Hideki Nishimura and Hiroshi Kaise and Kazuhiko Yamagami and Reiki Nishimura and Kazutaka Narui and Hirofumi Mukai and Naruto Taira},
  year = {2026},
  journal = {Breast Cancer},
  doi = {10.1007/s12282-026-01936-2},
  url = {https://doi.org/10.1007/s12282-026-01936-2}
}

RIS

TY  - JOUR
TI  - Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study
AU  - Takayuki Iwamoto
AU  - Yukari Uemura
AU  - Takashi Ishikawa
AU  - Azusa Jo
AU  - Hirohito Seki
AU  - Masahiro Kitada
AU  - Tsuyoshi Saito
AU  - Kimito Yamada
AU  - Shintaro Takao
AU  - Daisuke Takabatake
AU  - Toru Yokota
AU  - Yasuo Hozumi
AU  - Yuichiro Kikawa
AU  - Akimitsu Yamada
AU  - Uhi Toh
AU  - Hideki Nishimura
AU  - Hiroshi Kaise
AU  - Kazuhiko Yamagami
AU  - Reiki Nishimura
AU  - Kazutaka Narui
AU  - Hirofumi Mukai
AU  - Naruto Taira
PY  - 2026
JO  - Breast Cancer
DO  - 10.1007/s12282-026-01936-2
UR  - https://doi.org/10.1007/s12282-026-01936-2
ER  -

APA

Iwamoto, T., Uemura, Y., Ishikawa, T., Jo, A., Seki, H., Kitada, M., Saito, T., Yamada, K., Takao, S., Takabatake, D., Yokota, T., Hozumi, Y., Kikawa, Y., Yamada, A., Toh, U., Nishimura, H., Kaise, H., Yamagami, K., Nishimura, R., Narui, K., Mukai, H., & Taira, N. (2026). Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study. Breast Cancer. https://doi.org/10.1007/s12282-026-01936-2

Source records

crossref · retrieved 2026-11-08T02:23:24.516Z